An international research team has linked rare variations in a cell membrane protein to the wide variation in symptom severity that is a hallmark of porphyria, a rare disorder that often affects the ...
Givlaari (givosiran) is a prescription drug approved to treat acute hepatic porphyria (AHP). Givlaari comes as an injection given under the skin by a healthcare provider. Specifically, Givlaari is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results